Tim W.H. Chan

Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada.

Founded in 1964 by Art Phillips, Bob Hager and Rudy North, Phillips, Hager & North Investment Management (PH&N) is an investment advisor headquartered in Vancouver, British Columbia. The firm is an operating division of RBC Global Asset Management (RBC GAM), itself a wholly-owned subsidiary of the Royal Bank of Canada (NYSE: RY) which acquired PH&N in May 2008. In November 2010, PH&N amalgamated with their affiliate, RBC Asset Management, Inc. to form RBC GAM. RBC GAM is the fund manager and principal portfolio advisor of the PH&N Funds and the BonaVista Funds. The primary distributor of the PH&N Funds and the BonaVista Funds is Phillips, Hager & North Investments Funds Ltd., dba PH&N Investment services,